TY  - GEN
AU  - Takenaka,Katsuto
AU  - Shimoda,Kazuya
AU  - Uchida,Naoyuki
AU  - Shimomura,Taizo
AU  - Nagafuji,Koji
AU  - Kondo,Tadakazu
AU  - Shibayama,Hirohiko
AU  - Mori,Takehiko
AU  - Usuki,Kensuke
AU  - Azuma,Taichi
AU  - Tsutsumi,Yutaka
AU  - Tanaka,Junji
AU  - Dairaku,Hitomi
AU  - Matsuo,Keitaro
AU  - Ozawa,Keiya
AU  - Kurokawa,Mineo
AU  - Arai,Shunya
AU  - Akashi,Koichi
TI  - Clinical features and outcomes of patients with primary myelofibrosis in Japan: report of a 17-year nationwide survey by the Idiopathic Disorders of Hematopoietic Organs Research Committee of Japan
SN  - 1865-3774
PY  - 2017///0414
KW  - Adult
KW  - Androgens
KW  - therapeutic use
KW  - Antineoplastic Agents
KW  - Cohort Studies
KW  - Erythrocyte Transfusion
KW  - Female
KW  - Hematopoietic Stem Cell Transplantation
KW  - Humans
KW  - Hydroxyurea
KW  - Japan
KW  - epidemiology
KW  - Karyotype
KW  - Male
KW  - Middle Aged
KW  - Nitriles
KW  - Platelet Transfusion
KW  - Primary Myelofibrosis
KW  - diagnosis
KW  - Prognosis
KW  - Pyrazoles
KW  - Pyrimidines
KW  - Splenectomy
KW  - Surveys and Questionnaires
KW  - Survival Rate
KW  - Treatment Outcome
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1007/s12185-016-2102-3
ER  -